Edesa Biotech, Inc. (EDSA)
NASDAQ: EDSA · Real-Time Price · USD
2.490
+0.050 (2.05%)
At close: Sep 26, 2025, 4:00 PM EDT
2.390
-0.100 (-4.02%)
After-hours: Sep 26, 2025, 5:03 PM EDT
Edesa Biotech Market Cap
Edesa Biotech has a market cap or net worth of $17.52 million as of September 26, 2025. Its market cap has increased by 23.41% in one year.
Market Cap
17.52M
Enterprise Value
5.16M
1-Year Change
23.41%
Ranking
Category
Stock Price
$2.49
Market Cap Chart
Since November 5, 2015, Edesa Biotech's market cap has decreased from $74.90M to $17.52M, a decrease of -76.60%. That is a compound annual growth rate of -13.65%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 26, 2025 | 17.50M | 201.72% |
| Dec 31, 2024 | 5.80M | -60.00% |
| Dec 29, 2023 | 14.50M | -65.31% |
| Dec 30, 2022 | 41.80M | -45.07% |
| Dec 31, 2021 | 76.10M | 70.25% |
| Dec 31, 2020 | 44.70M | 45.13% |
| Dec 31, 2019 | 30.80M | 528.57% |
| Dec 31, 2018 | 4.90M | -42.35% |
| Dec 29, 2017 | 8.50M | -58.74% |
| Dec 30, 2016 | 20.60M | -62.34% |
| Dec 31, 2015 | 54.70M | -26.97% |
View and export this data all the way back to 2015.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 650.45B |
| Johnson & Johnson | 432.80B |
| AbbVie | 389.72B |
| UnitedHealth Group | 311.62B |
| Novo Nordisk | 242.68B |
| Novartis AG | 238.65B |
| Abbott Laboratories | 232.44B |
| AstraZeneca | 228.75B |